Dr. Imran Haque, a primary care doctor at Horizon Internal Medicine in North Carolina is excited about FDA approval for the digital pill, and says it will be helpful as new avenues of treatment are added. “I think the new system is an innovative way patients and their caregivers can learn about therapeutic management,” says Dr. Haque.
For the pharmaceutical company, Otsuka, which develops drugs for mental illness for the past 25 years, such treatment is also new. The introduction of Abilify MyCite should therefore be carried out very carefully with some selected health providers, the company said. These healthcare partners would in turn identify a small number of patients with schizophrenia, bipolar disorder and severe depression. This would allow professionals to gain experience, and show how the system works. Abilify MyCite is a joint medical development by Otsuka Pharmaceutical and Proteus Digital Health.
According to Imran Haque, people who need to take medication regularly could appreciate the digital pill. For example, if patients forget their scheduled daily medication their internist could remind the patient with an SMS message. “The most important feature is that doctors can monitor the actual physical use of the drug,” says Dr. Haque. To know more about him click here.
How It Works
When patients take this digital pill, integrated with a microchip, it becomes activated with the gastric juice from the stomach. From this point, data on body temperature, heart rate, and even the time the pill is ingested can be collected. The patient data transmits directly to the attending physician, who can then respond quickly to changes or deviations.
Demonstrating Clinical Excellence
Dr. Imran Haque offers residents in North Carolina his expertise and care, and his patients benefit from advanced knowledge at Horizon’s Internal Medicine Center. He provides expert diagnosis and treatments for various conditions. He’s backed by a full staff of fellow physicians and complimentary nursing staff.
Dr. Haque received his medical degree from Santo Domingo’s Universidad Iberoamericana University, and his Master’s of Internal Medicine in the Roanoke-Salem program.